Seven Eight Capital, LP Seres Therapeutics, Inc. Transaction History

Seven Eight Capital, LP

  • $918 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$18.46 - $24.36 $755,014 - $996,324
-40,900 Closed
0 $0
Q4 2020

Feb 09, 2021
SELL
$23.25 - $37.73 $244,125 - $396,164
-10,500 Reduced 20.43%
40,900 $1 Million
Q3 2020

Nov 16, 2020
BUY
$3.74 - $28.74 $192,236 - $1.48 Million
51,400 New
51,400 $1.46 Million

Others Institutions Holding MCRB

# of Institutions
96
Shares Held
46.3M
Call Options Held
119K
Put Options Held
466K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $118M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email